# Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor

> **NCT02069158** · PHASE1 · COMPLETED · sponsor: **Cristiana Sessa** · enrollment: 17 (actual)

## Conditions studied

- Breast Cancer
- NSCLC
- Ovary Cancer
- Endometrial Cancer
- Small Cell Lung Cancer (SCLC)
- Head and Neck (HNSCC)

## Interventions

- **DRUG:** PF-05212384
- **DRUG:** Paclitaxel
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT02069158
- **Lead sponsor:** Cristiana Sessa
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2019-05
- **Final completion:** 2019-05
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2019-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02069158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02069158, "Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02069158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*